Official United States Air Force Website
The Pathology department prepares and stores tissue from Radboudumc patients on a large scale. This is carried out in a uniform and well documented manner.
1. Opt-out
Left-over tissue in the Pathology Department’s diagnostic archive – from patients who have not signed an informed consent and:Have not objected to further use of their tissue for research and education purposes via mijnRadboud.
OR
Have objected to further use of their tissue for research and education purposes (this tissue remains available for diagnostic purposes only).
Both resection material and biopsies in this category are stored in the Pathology department’s diagnostic archive.
2. Opt-in
Left-over tissue for the Radboud Biobank – from patients who have signed an informed consent for one of the sub-biobanks accommodated by the Radboud Biobank.Resection tissue comes from the clinical setting via the central reception of the tissue preparation area and is eventually stored at the Radboud Biobank. In general 4 tissue blocks are stored (2x unaffected tissue, fresh frozen and paraffin embedded) plus 2x affected tissue samples, fresh frozen and paraffin embedded). The blocks are approximately 0,5 cm3. If desired it is possible to store more blocks depending on the size of the resected tissue. The maximum number of blocks is 16 (4x fresh frozen unaffected, 4x paraffin embedded unaffected, 4x fresh frozen affected, 4x paraffin embedded affected).
Biopsies are handled by the Pathology department according to the secondary use protocol, i.e. the tissue is prepared in the routine manner. Should (a part of) a biopsy be desired for research purposes and before the research proposal is presented to the CMO-light, the Radboud Biobank will check if there is enough tissue for the issuance and if both the sub-biobank and the pathologist concerned agree to the issuance.
N.B. Taking extra biopsies for a sub-biobank initiative is not permitted. A concrete research proposal with a specific informed consent that must be reviewed by the Radboudumc CMO commission is required for an extra biopsy (i.e. this research falls under the Dutch WMO legislation).
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

First implications of the Radboud Biobank new business model
15 July 2025It was communicated in an earlier news item that the Radboudumc Board of Directors decided to change the Radboud Biobank business model.
read more
Relocation of Radboud Biobank samples to Central Freezing Facility
15 July 2025The Radboud Biobank has now transferred almost all stored samples to the central freezing facility.
read more
Standardized Radboud Biobank procedures for sample handling in Elabgids
15 July 2025The Radboud Biobank is currently preparing to include all standardized Radboud Biobank procedures for sample handling in the eLabgids.
read more
Temporary new location Radboud Biobank Office
15 July 2025The Radboud Biobank office has moved to a temporary new location: route 832 - M325.04.255 (building F).
read more
Europe Biobank Week 2025
15 July 2025The Europe Biobank Week 2025 was a great success for the Dutch biobank community with a strong presence of Dutch biobanking and biomedical research.
read more
National Biobanks & Collections Dag 2025
6 May 2025The second edition of the National Biobanks & Collections Day took place on March 27, 2025, in Nijmegen and attracted 150 participants from all over the Netherlands.
read more